The global multiple sclerosis treatment market is likely to grow at a 3.5% CAGR between 2017- 2023, according to the recent Market Research Future (MRFR) report. Multiple sclerosis or MS is a potentially disabling disease both of the spinal cord & the brain. The symptoms, duration, and severity can differ from one person to another. Some of the common symptoms include impaired coordination, fatigue, pain, and vision loss.